Comparing incidence of heart failure in individuals with enlarged cardiac chambers versus diabetes

Read full text
Authors: Seyed Reza Mirjalili, Kyle Atlas, Anthony P. Reeves, Chenyu Zhang, Jakob Wasserthal, Amir Azimi, Ali Hashemi, MohammadHossein MozafaryBazargany, Amir Ghaffari Jolfayi, Thomas Atlas, Claudia I. Henschke, David F. Yankelevitz
+24 more Javier J. Zulueta, Jeffrey Mechanick, Andrea D Branch, Ning Ma, Rowena Yip, Wenjun Fan, Sion K. Roy, Khurram Nasir, Sabee Molloi, Zahi Fayad, Michael V. McConnell, Ioannis A. Kakadiaris, George Abela, Rozemarijn Vliegenthart, David J. Maron, Jagat Narula, Kim A. Williams, Prediman K. Shah, Matthew J. Budoff, Daniel Levy, Roxana Mehran, Robert A. Kloner, Nathan D. Wong, Morteza Naghavi
Cited by: 1
References: 31

Abstract

Background Opportunistic cardiac chamber volumetry derived from coronary artery calcium (CAC) scans using the AI-CVD platform predicts heart failure (HF) independent of conventional risk factors. Type 2 diabetes mellitus (T2DM), which classifies individuals as Stage A HF, is associated with chamber enlargement; however, the HF risk associated with chamber enlargement in the absence of T2DM has not been characterized. Methods We analyzed left atrial (LA) and left ventricular (LV) volumes and mass, indexed to body surface area, using AI-CVD chamber volumetry of 7585 asymptomatic participants in the pooled cohort of Multi-Ethnic Study of Atherosclerosis (MESA) and Framingham Heart Study (FHS) second, and third generation (MESA & FHS; mean age 62.7 ± 14.6 years, 48.6 % male, 10.6 % with T2DM). Chambers were classified as enlarged (≥95th) or normal (

Fields of Study & Subjects

Cardiac Structural Anomalies and Repair Cardiac pacing and defibrillation studies Cardiovascular Function and Risk Factors

Publication details

Journal / source
American Journal of Preventive Cardiology
Publisher
Elsevier BV
Volume
29
Pages
101656–101656
Publication date
1 May 2026
Language
EN